Stochastic modeling of human RBC alloimmunization: Evidence for a distinct population of immunologic responders

Blood

Volumn 112, Issue 6, 2008, Pages 2546-2553

  Higgins, John M ^a,b   Sloan, Steven R ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY;

ADULT; ALLOIMMUNIZATION; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; GRAFT RECIPIENT; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; STOCHASTIC MODEL; BIOLOGY; BLOOD; BLOOD TRANSFUSION; FACTUAL DATABASE; GENETIC PREDISPOSITION; IMMUNOLOGY; METHODOLOGY; RISK FACTOR; STATISTICS;

BLOOD TRANSFUSION; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; ERYTHROCYTES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISOANTIBODIES; RISK FACTORS; STOCHASTIC PROCESSES;

EID: 55249115625     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-146415     Document Type: Article

References (21)

1. Hillyer CD. Blood Banking Transfusion Medicine: Basic Principles & Practice. 1st ed. Philadelphia, PA: Churchill Livingstone; 2003:11-61.
2. Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev. 2008;22:117-132.
3. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006;46:1526-1536.
4. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fy(a) and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion. 2006;46:1328-1333.
5. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle-cell disease. Blood. 1990;76:1431-1437.
6. Rosse WF, Telen MJ. Ware RE. Transfusion Support for Patients With Sickle Cell Disease. Bethesda, MD:AABB Press; 1998:113.
7. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sicklecell-anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322:1617-1621.
8. Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briet E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion. 2007;47:2066-2071.
9. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red-cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med. 1995;119:42-45.
10. Sarnaik S, Schornack J, Lusher JM. The incidence of development of irregular red-cell antibodies in patients with sickle-cell-anemia. Transfusion. 1986;26:249-252.
11. Brecher ME, American Association of Blood Banks. Technical Manual: AABB. 15th ed. Bethesda, MD: American Association of Blood Banks; 2005:752-754.
12. Cate JC, Reilly N. Evaluation and implementation of the gel test for indirect antiglobulin testing in a community hospital laboratory. Arch Pathol Lab Med. 1999;123:693-697.
13. Weisbach V, Kohnhauser T, Zimmermann R, et al. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med. 2006;16:276-284.
14. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 9th ed. Oxford, United Kingdom: Blackwell Scientific; 1993:102-104.
15. Ross SM. A First Course in Probability. 5th ed. Upper Saddle River, NJ: Prentice Hall; 1998:514.
16. Taylor HM, Karlin S. An Introduction to Stochastic Modeling (3rd ed). San Diego, CA: Academic Press; 1998:631.
17. Schonewille H, van de Watering LMG, Loomans DSE, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006;46:250-256.
18. HeddleNM, Soutar RL, Ohoski PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization posttransfusion. Br J Haematol. 1995;91:1000-1005.
19. Schonewille H, van de Watering LMG, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion. 2006;46:630-635.
20. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39:763-771.
21. Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007; 110: 2736-2743.